Found: 6
Select item for more details and to access through your institution.
Carbon 14 and Carbon 13 Syntheses of Velagliflozin.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 5, p. 180, doi. 10.1002/jlcr.4091
- By:
- Publication type:
- Article
Stable isotope synthesis of glycine transporter 1 inhibitor Iclepertin (BI 425809) and its major metabolites.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2023, v. 66, n. 13, p. 414, doi. 10.1002/jlcr.4063
- By:
- Publication type:
- Article
Carbon 14 and stable isotope synthesis of two potent and selective phosphodiesterase type 4 inhibitors.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2023, v. 66, n. 11, p. 353, doi. 10.1002/jlcr.4054
- By:
- Publication type:
- Article
Carbon 14 synthesis of glycine transporter 1 inhibitor Iclepertin (BI 425809) and its major metabolites.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2023, v. 66, n. 11, p. 336, doi. 10.1002/jlcr.4051
- By:
- Publication type:
- Article
Synthesis of BI 894416 and BI 1342561, two potent and selective spleen tyrosine kinase inhibitors, labeled with carbon 14 and with deuterium.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2023, v. 66, n. 4-6, p. 155, doi. 10.1002/jlcr.4024
- By:
- Publication type:
- Article
Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2023, v. 66, n. 4-6, p. 145, doi. 10.1002/jlcr.4022
- By:
- Publication type:
- Article